Boston Common Asset Management LLC lessened its stake in shares of Aetna Inc (NYSE:AET) by 9.9% in the 4th quarter, reports. The institutional investor owned 8,093 shares of the company’s stock after selling 887 shares during the period. Boston Common Asset Management LLC’s holdings in Aetna were worth $1,460,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of AET. Orbimed Advisors LLC lifted its position in shares of Aetna by 57.3% during the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after buying an additional 508,600 shares during the period. CI Investments Inc. acquired a new stake in Aetna during the 4th quarter valued at $87,552,000. Point72 Asset Management L.P. increased its holdings in Aetna by 233.9% during the 3rd quarter. Point72 Asset Management L.P. now owns 429,353 shares of the company’s stock valued at $68,271,000 after purchasing an additional 300,753 shares in the last quarter. Ardevora Asset Management LLP acquired a new stake in Aetna during the 3rd quarter valued at $35,507,000. Finally, Milestone Resources Group Ltd acquired a new stake in Aetna during the 4th quarter valued at $35,385,000. Institutional investors and hedge funds own 87.10% of the company’s stock.

Shares of Aetna Inc (NYSE AET) opened at $177.38 on Tuesday. The company has a market capitalization of $57,840.00, a price-to-earnings ratio of 30.85, a PEG ratio of 1.43 and a beta of 0.60. Aetna Inc has a 52 week low of $121.01 and a 52 week high of $194.40. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.68 and a quick ratio of 0.53.

Aetna (NYSE:AET) last released its earnings results on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.18 by $0.07. The company had revenue of $14.74 billion during the quarter, compared to analysts’ expectations of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The business’s revenue for the quarter was down 6.2% on a year-over-year basis. During the same period last year, the firm earned $0.08 EPS. sell-side analysts predict that Aetna Inc will post 10.99 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were paid a $0.50 dividend. The ex-dividend date was Wednesday, January 10th. This represents a $2.00 annualized dividend and a dividend yield of 1.13%. Aetna’s dividend payout ratio (DPR) is currently 34.78%.

A number of equities research analysts recently weighed in on AET shares. BMO Capital Markets raised their price target on Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a report on Friday, October 27th. Morgan Stanley cut Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price target for the company. in a report on Wednesday, December 20th. Cantor Fitzgerald cut Aetna from an “overweight” rating to a “neutral” rating in a report on Thursday, October 26th. Zacks Investment Research raised Aetna from a “hold” rating to a “strong-buy” rating and set a $184.00 price target for the company in a report on Wednesday, October 25th. Finally, Credit Suisse Group reaffirmed a “neutral” rating and set a $195.00 price target (up from $174.00) on shares of Aetna in a report on Wednesday, December 6th. Ten research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Aetna presently has a consensus rating of “Buy” and a consensus target price of $185.94.

TRADEMARK VIOLATION WARNING: “Boston Common Asset Management LLC Has $1.46 Million Position in Aetna Inc (AET)” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with's FREE daily email newsletter.